Endo International PLC (NASDAQ:ENDP) – Stock analysts at Oppenheimer Holdings upped their FY2020 EPS estimates for Endo International PLC in a research report issued to clients and investors on Tuesday. Oppenheimer Holdings analyst D. Archila now anticipates that the company will earn $3.67 per share for the year, up from their previous forecast of $3.49. Oppenheimer Holdings has a “Hold” rating on the stock.

Endo International PLC (NASDAQ:ENDP) last released its quarterly earnings data on Tuesday, August 8th. The company reported $0.93 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.19. The business had revenue of $875.73 million during the quarter, compared to analyst estimates of $832.66 million. Endo International PLC had a positive return on equity of 37.58% and a negative net margin of 126.93%. The company’s revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the business posted $0.86 EPS.

TRADEMARK VIOLATION WARNING: “FY2020 EPS Estimates for Endo International PLC (ENDP) Lifted by Analyst” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/08/11/fy2020-eps-estimates-for-endo-international-plc-endp-lifted-by-analyst.html.

Several other equities research analysts also recently weighed in on the stock. BMO Capital Markets reiterated a “market perform” rating and set a $11.00 target price (down previously from $15.00) on shares of Endo International PLC in a research note on Friday. Morgan Stanley decreased their target price on shares of Endo International PLC from $12.00 to $8.00 and set an “equal weight” rating for the company in a research note on Thursday. Cowen and Company reiterated a “hold” rating and set a $16.00 target price on shares of Endo International PLC in a research note on Thursday. Citigroup Inc. reiterated a “neutral” rating and set a $11.00 target price (down previously from $14.00) on shares of Endo International PLC in a research note on Thursday. Finally, Mizuho reiterated a “buy” rating and set a $19.00 target price on shares of Endo International PLC in a research note on Thursday. Three analysts have rated the stock with a sell rating, sixteen have given a hold rating and five have issued a buy rating to the stock. Endo International PLC currently has an average rating of “Hold” and a consensus price target of $14.86.

Endo International PLC (ENDP) traded up 0.53% during trading on Friday, hitting $7.59. The company’s stock had a trading volume of 8,955,417 shares. The company has a 50-day moving average of $11.04 and a 200 day moving average of $11.59. The firm’s market cap is $1.69 billion. Endo International PLC has a one year low of $7.41 and a one year high of $24.93.

Several hedge funds and other institutional investors have recently modified their holdings of ENDP. HL Financial Services LLC boosted its position in shares of Endo International PLC by 1.0% in the second quarter. HL Financial Services LLC now owns 52,800 shares of the company’s stock worth $590,000 after buying an additional 500 shares during the period. Amalgamated Bank boosted its position in shares of Endo International PLC by 2.0% in the first quarter. Amalgamated Bank now owns 32,357 shares of the company’s stock worth $361,000 after buying an additional 619 shares during the period. Meeder Asset Management Inc. boosted its position in shares of Endo International PLC by 1.4% in the second quarter. Meeder Asset Management Inc. now owns 48,699 shares of the company’s stock worth $544,000 after buying an additional 677 shares during the period. Capstone Asset Management Co. boosted its position in shares of Endo International PLC by 3.1% in the second quarter. Capstone Asset Management Co. now owns 32,035 shares of the company’s stock worth $358,000 after buying an additional 960 shares during the period. Finally, Arizona State Retirement System boosted its position in shares of Endo International PLC by 1.5% in the second quarter. Arizona State Retirement System now owns 83,700 shares of the company’s stock worth $935,000 after buying an additional 1,200 shares during the period. 93.00% of the stock is owned by institutional investors and hedge funds.

In other Endo International PLC news, COO Terrance J. Coughlin acquired 20,000 shares of the company’s stock in a transaction dated Thursday, August 10th. The stock was acquired at an average cost of $7.70 per share, with a total value of $154,000.00. Following the purchase, the chief operating officer now directly owns 181,369 shares in the company, valued at approximately $1,396,541.30. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.50% of the company’s stock.

Endo International PLC Company Profile

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Earnings History and Estimates for Endo International PLC (NASDAQ:ENDP)

Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with MarketBeat.com's FREE daily email newsletter.